Jun 22, 2026Filed0001683168-26-005003
All companies
Trade Aethlon Medical Inc
Aethlon Medical files Amendment No. 1 to its at-the-market prospectus supplement (ATM) to update eligible share amount
AE
Aethlon Medical Inc
AEMDPublic
PublicUnited States(NASDAQ-CM)Best valuation $3.27M1 market
Public listing
Listed· NASDAQ-CM· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-edgar, sec-harvest, nasdaq
IPO Calendar · NASDAQ-CMIPO
AEMDPrice
$1.38
24h
-26.98%
Valuation
$3.27M
24h volume
$984.49K
Type
IPO
Trade Aethlon Medical IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 2h ago
Financials
UnprofitableFrom SEC filings, latest FY ending Mar 31, 2024 · CIK 0000882291.
Revenue · -100.00% YoY
$0
Net income
-$7.15M
Gross margin
—
Cash
$5.03M
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | — | — | $0 | $574.25K | $294.17K |
| Operating income | -$7.29M | -$9.34M | -$12.64M | -$11.9M | -$10.42M |
| Net income | -$7.15M | -$13.39M | -$12.21M | -$12.03M | -$10.42M |
| R&D expense | $1.91M | $2.21M | $2.52M | $2.75M | $2.34M |
| Cash & equivalents | $5.03M | $5.5M | $5.44M | $14.53M | $17.07M |
| Total assets | $6.33M | $7.36M | $8.25M | $17.51M | $19.42M |
| Total liabilities | $1.45M | $2.24M | $2.48M | $2.44M | $2.43M |
| Shareholders' equity | $4.89M | $5.12M | $5.77M | $15.06M | $16.99M |
SEC IPO filings
FiledEDGAR filings resolved from AEMD / CIK 0000882291.
May 5, 2026Confidential draft0001683168-26-003479
424B3FORM 434(B)(3)
Jan 27, 2026Final prospectus0001683168-26-000566
Jan 16, 2026Effective9999999995-26-000202
424B3PROSPECTUS
Jan 16, 2026Final prospectus0001683168-26-000376
Jan 7, 2026Filed0001683168-26-000137
Jan 2, 2026Effective9999999995-26-000036
CORRESPfilename1.htm
Dec 30, 2025SEC correspondence0001683168-25-009432
UPLOADfilename1.pdf
Dec 30, 2025SEC correspondence0000000000-25-011894
424B4PROSPECTUS
Sep 5, 2025Final prospectus0001683168-25-006701
Sep 4, 2025Effective9999999995-25-002837
CORRESPfilename1.htm
Aug 29, 2025SEC correspondence0001683168-25-006559
Latest Aethlon Medical Inc IPO news
Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.
U.S. Securities and Exchange Commission (SEC)Jun 4, 2026Market news
Aethlon Medical reported that on June 4, 2026 it filed Amendment No. 1 to its prospectus supplement for its at-the-market (ATM) offering program, updating the amount of shares eligible for sale under General Instruction I.B.6 of Form S-3.
Aethlon Medical Inc IPO — frequently asked questions
- When did Aethlon Medical Inc go public?
- Aethlon Medical Inc has already gone public and now trades publicly on NASDAQ-CM under the ticker AEMD.
- Can I buy Aethlon Medical Inc stock?
- Yes — Aethlon Medical Inc is publicly traded on NASDAQ-CM as AEMD. You can follow its live price, valuation and post-IPO performance above.
- What is Aethlon Medical Inc's valuation?
- Aethlon Medical Inc's most recent valuation tracked here is $3.27M, derived from live market prices.